Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (451-460 of 962) with videos related to

Pageof 97
Sort By:
BMC Public Health|July 2, 2010
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA)Fernando Rodríguez-Artalejo, Eliseo Guallar, Claudio Borghi, et al.
American Heart Journal|February 15, 2011
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromesSanjit S Jolly, Kari Niemelä, Denis Xavier, et al.
Heart (British Cardiac Society)|February 23, 2019
Living alone and cardiovascular disease outcomesSumeet Gandhi, Shaun G Goodman, Nicola Greenlaw, et al.
Journal of the American College of Cardiology|August 11, 2018
Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE SubstudyJohn D Horowitz, Raffaele De Caterina, Tamila Heresztyn, et al.
Clinical Chemistry|December 1, 2011
Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes studyÅxel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.
American Heart Journal|September 18, 2012
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trialJan H Cornel, Richard C Becker, Shaun G Goodman, et al.
European Heart Journal|November 13, 2012
Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosisDharam J Kumbhani, P Gabriel Steg, Christopher P Cannon, et al.
JAMA|October 4, 2012
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery diseaseSripal Bangalore, Gabriel Steg, Prakash Deedwania, et al.
American Heart Journal|February 20, 2026
A Comprehensive Set of Per-Protocol Analyses of the Myocardial Ischemia and Transfusion (MINT) TrialBrandon M Herbert, Jeffrey L Carson, Marnie Bertolet, et al.
European Heart Journal|April 19, 2018
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trialsHarsh B Golwala, Christopher P Cannon, Ph Gabriel Steg, et al.
Pageof 97

Showing results (451-460 of 962) with videos related to

Sort By:
Pageof 97
BMC Public Health|July 2, 2010
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA)Fernando Rodríguez-Artalejo, Eliseo Guallar, Claudio Borghi, et al.
American Heart Journal|February 15, 2011
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromesSanjit S Jolly, Kari Niemelä, Denis Xavier, et al.
Heart (British Cardiac Society)|February 23, 2019
Living alone and cardiovascular disease outcomesSumeet Gandhi, Shaun G Goodman, Nicola Greenlaw, et al.
Journal of the American College of Cardiology|August 11, 2018
Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE SubstudyJohn D Horowitz, Raffaele De Caterina, Tamila Heresztyn, et al.
Clinical Chemistry|December 1, 2011
Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes studyÅxel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.
American Heart Journal|September 18, 2012
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trialJan H Cornel, Richard C Becker, Shaun G Goodman, et al.
European Heart Journal|November 13, 2012
Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosisDharam J Kumbhani, P Gabriel Steg, Christopher P Cannon, et al.
JAMA|October 4, 2012
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery diseaseSripal Bangalore, Gabriel Steg, Prakash Deedwania, et al.
American Heart Journal|February 20, 2026
A Comprehensive Set of Per-Protocol Analyses of the Myocardial Ischemia and Transfusion (MINT) TrialBrandon M Herbert, Jeffrey L Carson, Marnie Bertolet, et al.
European Heart Journal|April 19, 2018
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trialsHarsh B Golwala, Christopher P Cannon, Ph Gabriel Steg, et al.
Pageof 97